IO102
IO102-012 / KN-764
Phase 2 mab completed
Quick answer
IO102 for NSCLC is a Phase 2 program (mab) at IO Biotech with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IO Biotech
- Indication
- NSCLC
- Phase
- Phase 2
- Modality
- mab
- Status
- completed